258854-17-0

Basic information

• Product Name: 1-O-Allyl 6-O-trityl-α-D-galactopyranoside
• Synonyms: 1-O-Allyl 6-O-trityl-α-D-galactopyranoside
• CAS NO: 258854-17-0
• Molecular Weight: 462.543
• Mol File: 258854-17-0.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 1-O-Allyl 6-O-trityl-α-D-galactopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: 1-O-Allyl 6-O-trityl-α-D-galactopyranoside(258854-17-0)
• EPA Substance Registry System: 1-O-Allyl 6-O-trityl-α-D-galactopyranoside(258854-17-0)

Safety Data

• Hazardous Substances Data: 258854-17-0(Hazardous Substances Data)

Upstream product

• 10257-28-0 D-Galactose 
• 76-83-5 trityl chloride 
• 2595-07-5 allyl D-galactopyranoside 
• 1122-58-3 dmap 
• 48149-72-0 (2S,3R,4S,5R,6R)-2-Allyloxy-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol 

Downstream Products

• 103-50-4 dibenzyl ether 
• 56083-16-0 1-O-Allyl 2,3,4-tri-O-benzyl-α-D-galactopyranoside 
• 195316-90-6 allyl (2,3,4-tri-O-benzoyl-6-O-chloroacetyl-β-D-glucopyranosyl)-(1->6)-2,3,4-tri-O-benzoyl-α-D-galactopyranoside 
• 195316-95-1 allyl [2,3-di-O-benzoyl-4-O-(3-fluoro-1,1,3,3-tetraisopropyl-1,3-disiloxane-1-yl)-β-D-glucopyranosyl]-(1->6)-2,3,4-tri-O-benzoyl-α-D-galactopyranoside 
• 195316-94-0 allyl [2,3-di-O-benzoyl-4,6-O-(1,1,3,3-tetraisopropyl-1,3-disiloxane-1,3-diyl)-β-D-glucopyranosyl]-(1->6)-2,3,4-tri-O-benzoyl-α-D-galactopyranoside 
• 195316-93-9 allyl (2,3,4-tri-O-benzoyl-β-D-glucopyranosyl)-(1->6)-2,3,4-tri-O-benzoyl-α-D-galactopyranoside 
• 195316-91-7 allyl 2,3,4-tri-O-benzoyl-6-O-trimethylsilyl-α-D-galactopyranoside 
• 195316-89-3 allyl 2,3,4-tri-O-benzoyl-α-D-galactopyranoside 

Relevant articles and documents

Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3

The present invention provides a protein- and peptide-free conjugate comprising a synthetic carbohydrate and a carrier molecule, wherein the synthetic carbohydrate is a Streptococcus pneumoniae type 3 capsular polysaccharide related carbohydrate and the carrier molecule is a glycosphingolipid. Said conjugate and pharmaceutical composition thereof are useful for immunization against diseases associated with Streptococcus pneumoniae, and more specifically against diseases associated with Streptococcus pneumoniae type 3.

CARBOHYDRATE-GLYCOLIPID CONJUGATE VACCINES

The present invention relates to the field of synthesizing and biologically evaluating of a novel class of carbohydrate-based vaccines. The new vaccines consist of a multi-modular structure which allows applying the vaccine to a whole variety of pathogenes. This method allows preparing vaccines against all pathogens expressing immunogenic carbohydrate antigens. As conjugation of antigenic carbohydrates to proteins is not required the conjugate vaccine is particularly heat stable. No refrigeration is required, a major drawback of protein-based vaccines.

Novel sulfofucosylacylglycerol derivatives and use thereof as medicaments

Novel sulfofucosylacylglycerol derivatives represented by General Formula (1): 1where R101 represents an acyl residue of a higher fatty acid and R102 represents a hydrogen atom or an acyl residue of a higher fatty acid. The derivati